sBCMA Variants and FC Fusion Proteins Thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 5, 2024
app pub date -
Aug 11, 2021
filing date -
Aug 12, 2020
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The invention is directed to novel sBCMA variants and sBCMA variant—Fc fusion proteins, polynucleotides encoding the sBCMA variants and/or sBCMA variant—Fc fusion proteins, methods of making the sBCMA variants and/or sBCMA variant—Fc fusion proteins, and methods of using compositions comprising the sBCMA variants and/or sBCMA variant—Fc fusion proteins, for example, in treating diseases such as tumors/cancers, immunoregulatory disorders, etc.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully